GI Research Institute, 770-1190 Hornby St
Welcome,         Profile    Billing    Logout  
 3 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Bressler, Brian
VERDICT, NCT04259138: Determination of the Optimal Treatment Target in Ulcerative Colitis

Active, not recruiting
4
672
Europe, Canada, US, RoW
Treatment Algorithm A, vedolizumab, Treatment Algorithm B, Treatment Algorithm C
Alimentiv Inc., Takeda Development Center Americas, Inc.
Colitis, Ulcerative
03/26
03/26
NCT06233461: A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Recruiting
2
268
Europe, Canada, Japan, US, RoW
TAK-279, Zasocitinib, Placebo
Takeda
Crohn's Disease
09/26
07/27
NCT06254950: A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis

Recruiting
2
207
Europe, Canada, Japan, US, RoW
TAK-279, Zasocitinib, Placebo
Takeda
Ulcerative Colitis
09/26
08/27
NCT02721719: The Role of CD4+ T Cell Subsets in the Mechanism of Action of Vedolizumab in Ulcerative Colitis

Active, not recruiting
N/A
50
Canada
University of British Columbia
Ulcerative Colitis
12/23
12/24
IBDDysplasia, NCT04067778: IBD Neoplasia Surveillance Pilot RCT

Completed
N/A
600
Canada
Intervention Group, Control Group
Ottawa Hospital Research Institute, Health Sciences Centre, Winnipeg, Manitoba, Western University, Canada, University of Toronto, Hamilton Health Sciences Corporation, Thunder Bay Regional Health Sciences Centre, Eastern Health, McGill University Health Centre/Research Institute of the McGill University Health Centre, Providence Health & Services, Royal Jubilee Hospital, University of Alberta, MOUNT SINAI HOSPITAL, Nova Scotia Health Authority
Inflammatory Bowel Diseases, Colonic Neoplasms, Dysplasia
09/22
10/22
NCT05809999: IBD Neoplasia Surveillance RCT

Recruiting
N/A
1952
Canada
Standard colonoscopy with targeted biopsies
Ottawa Hospital Research Institute
Colonic Neoplasms, Inflammatory Bowel Diseases, Dysplasia
12/25
02/26

Download Options